淋巴系统
微生物群
生物
病理
肠道菌群
炎症性肠病
肠道微生物群
发病机制
疾病
拟杆菌
免疫学
医学
生物信息学
遗传学
16S核糖体RNA
细菌
作者
Felix Becker,Felicity N. E. Gavins,Jane Fontenot,Paul Jordan,J.Y. Yun,Rona S. Scott,Paula Polk,R. Ellen Friday,Moheb Boktor,Melany Musso,Emily Romero,Sharon Boudreaux,J. H. Simmons,Dana L. Hasselschwert,Jason Goetzmann,John A. Vanchiere,Urška Cvek,Marjan Trutschl,Phillip Kilgore,J. Steven Alexander
标识
DOI:10.1016/j.pathophys.2019.06.004
摘要
The pathogenesis of inflammatory bowel disease (IBD) has been linked with lymphostasis, but whether and how lymphatic obstruction might disturb the intestinal microbiome in the setting of Crohn's Disease (CD) is currently unknown. We employed a new model of CD in African Green monkeys, termed 'ATLAS' (African green monkey truncation of lymphatics with obstruction and sclerosis), to evaluate how gut lymphatic obstruction alters the intestinal microbiome at 7, 21 and 61 days. Remarkable changes in several microbial sub- groupings within the gut microbiome were observed at 7 days post-ATLAS compared to controls including increased abundance of Prevotellaceae and Bacteroidetes-Prevotella-Porphyromonas (BPP), which may contribute to disease activity in this model of gut injury. To the best of our knowledge, these findings represent the first report linking lymphatic structural/gut functional changes with alterations in the gut microbiome as they may relate to the pathophysiology of CD.
科研通智能强力驱动
Strongly Powered by AbleSci AI